MCRM
LLY icon

Midway Capital Research & Management’s Eli Lilly LLY Stock Holding History

Midway Capital Research & Management’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.4K Hold
2
– – ﹤0.01% 108
2026
Q1 		$1.84K Buy
+2
New +$2.03K ﹤0.01% 113

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Midway Capital Research & Management's LLY Position: Q2 2026 in Review

Midway Capital Research & Management held its Eli Lilly (LLY) position steady in Q2 2026 at 2 shares worth $2.4K. The position accounts for ﹤0.01% of the portfolio, ranked #108.

Midway Capital Research & Management first reported a position in LLY in Q1 2026 and has held it in 2 quarters since. 4,598 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Midway Capital Research & Management held 2 shares of Eli Lilly worth $2.4K as of Q2 2026.
  • Midway Capital Research & Management left its Eli Lilly share count unchanged in Q2 2026.
  • Eli Lilly made up ﹤0.01% of Midway Capital Research & Management's portfolio in Q2 2026, its #108 holding.
  • Midway Capital Research & Management first reported a position in Eli Lilly in Q1 2026 and has held it in 2 quarters since.
  • 4,598 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Midway Capital Research & Management's 13F filing for Q2 2026, filed 14 Jul 2026.